ConductScience.org, home

Paper37037178

Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy.

Shirasawa M and 21 others. Lung Cancer, 2023. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy. Papers, record 37037178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37037178

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy.
PubMed
Journal
Lung Cancer
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
2.58
iCite
Revised in PubMed
2023-05-10
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shirasawa MMasayuki
2Yoshida TTatsuya
3Shiraishi KKouya
4Takigami AAyako
5Takayanagi DDaisuke
6Imabayashi TTatsuya
7Matsumoto YYuji
8Masuda KKen
9Shinno YYuki
10Okuma YYusuke
11Goto YYasushi
12Horinouchi HHidehito
13Yotsukura MMasaya
14Yoshida YYukihiro
15Nakagawa KKazuo
16Tsuchida TTakaaki
17Hamamoto RRyuji
18Yamamoto NNoboru
19Motoi NNoriko
20Kohno TTakashi

Source PubMed

See all 22 authorsDownload CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Small Cell Lung CarcinomaMajor topic
Lung NeoplasmsMajor topic
Humans
Etoposide
Retrospective Studies
Phenotype

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
42705850[Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer Based on Molecular Subtyping].Zhongguo Fei Ai Za Zhi2026https://conductscience.org/library/papers/42705850PubMed
42701198Integrating molecular subtypes, genomics and functional dependencies to identify context-specific therapeutic vulnerabilities in small cell lung cancer.Biomark Res2026https://conductscience.org/library/papers/42701198PubMed
42291341Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42291341PubMed
41783745Potential Immune Microenvironment Biomarkers in SCLC: J-TAIL-2 Observational Study.JTO Clin Res Rep2026https://conductscience.org/library/papers/41783745PubMed
41454081Prognostic utility of baseline ASCL1/INSM1 expression and neutrophil-lymphocyte ratio in unresectable SCLC treated with first-line chemoimmunotherapy with or without radiotherapy.Front Med2025https://conductscience.org/library/papers/41454081PubMed
41446220CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level.bioRxiv2025https://conductscience.org/library/papers/41446220PubMed
41220942Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer.Front Oncol2025https://conductscience.org/library/papers/41220942PubMed
41220940A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America.Front Oncol2025https://conductscience.org/library/papers/41220940PubMed
41187938TGFβ1 and SMAD3 Expression Are Associated With Survival After the Immune Checkpoint Inhibitor Therapy for Small Cell Lung Cancer.Cancer Rep (Hoboken)2025https://conductscience.org/library/papers/41187938PubMed
41132975Metabolic phenotype and gender may predict treatment outcomes of atezolizumab in extensive-stage small cell lung cancer.Transl Lung Cancer Res2025https://conductscience.org/library/papers/41132975PubMed
41001033Case Report: A small cell lung cancer transformed from an EGFR-mutated Adenocarcinoma demonstrated a long-term remission to anti PD-1 antibody.Front Oncol2025https://conductscience.org/library/papers/41001033PubMed
40964483State of the art in treatment of small cell lung cancer.Ther Adv Med Oncol2025https://conductscience.org/library/papers/40964483PubMed
40931642Prognostic values and clinical significance of POU2F3 expression in neuroendocrine carcinomas: a meta-analysis with a focus on small cell lung cancer.Ann Med2025https://conductscience.org/library/papers/40931642PubMed
40543507MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer.Cell Rep Med2025https://conductscience.org/library/papers/40543507PubMed
40386726Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature.Transl Lung Cancer Res2025https://conductscience.org/library/papers/40386726PubMed
40333678Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives.Molecules2025https://conductscience.org/library/papers/40333678PubMed
39941061The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/39941061PubMed
39789380Adoptive cell therapies in thoracic malignancies: a comprehensive review.Clin Transl Oncol2026https://conductscience.org/library/papers/39789380PubMed
39723215Advances in biomarkers for immunotherapy in small-cell lung cancer.Front Immunol2024https://conductscience.org/library/papers/39723215PubMed
39682568Novel Immunohistochemical Profiling of Small-Cell Lung Cancer: Correlations Between Tumor Subtypes and Immune Microenvironment.Diagnostics (Basel)2024https://conductscience.org/library/papers/39682568PubMed

See all 24 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AP2B1163PubTator's text mininghttps://conductscience.org/library/genes/163NCBI Gene
ASCL1429PubTator's text mininghttps://conductscience.org/library/genes/429NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
NEUROD14760PubTator's text mininghttps://conductscience.org/library/genes/4760NCBI Gene
POU2F325833PubTator's text mininghttps://conductscience.org/library/genes/25833NCBI Gene
YAP110413PubTator's text mininghttps://conductscience.org/library/genes/10413NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37037178

GET https://conductscience.org/api/papers/v1/37037178/authors?page=2